GENITALIA OUTGROWTH AND HYPOSPADIAS

生殖器生长和尿道下裂

基本信息

  • 批准号:
    9317645
  • 负责人:
  • 金额:
    $ 34.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-04-01 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

Abstract Genital malformation including hypospadias represents the second most common male birth defect after cardiac defect. In the past 50 years, hypospadias incidence has doubled along with other male reproductive problems. It is suspected that fetal exposure to endocrine disruptors may have contributed to this increase. However, the etiology of hypospadias is still largely unclear. Both environmental and genetic factors are involved. In fact, our understandings of genital development in general are still very limited. A complete understanding of genetic pathways governing genital development and masculinization and how perturbations of these pathways lead to genital malformations will have immense applications to improve global health. In the past few years, we have performed comprehensive genetic analyses on genital tubercle (GT) development in the mouse and established a conserved genetic pathway (Wnt/β-cateninSp8Fgf8) in regulating body appendage outgrowth, including limbs and external genitalia. Genetic interactions between Wnt and Shh pathways in regulating both genitalia outgrowth and masculinization have also been described. Together, these studies laid the foundation for understanding posterior embryonic development as well as how environmental factors can influence genitalia development and cause hypospadias. Based on these findings, this proposal will continue to use mouse genetics including a series of conditional mutant mice to investigate a novel genetic pathway regulating GT outgrowth. In Aim I, We will characterize several knockout mouse models to build a genetic pathway regulating GT outgrowth and patterning. In Aim II, we will use a novel and highly innovative Split DamID technique to identify in vivo downstream targets of androgen receptor and β-catenin during genital masculinization. Together, these studies should greatly improve our understanding of genitalia development and hypospadias formation. Our long term goal is to use mouse molecular genetics to understand the process of genital development and masculinization and the etiology of genital malformations, such as hypospadias.
摘要 包括尿道下裂在内的生殖器畸形是第二大常见的男性出生缺陷, 心脏缺陷在过去的50年里,尿道下裂的发病率增加了沿着,随着其他男性生殖 问题人们怀疑胎儿暴露于内分泌干扰物可能导致了这种增加。 然而,尿道下裂的病因仍然很大程度上不清楚。环境和遗传因素都是 涉案事实上,我们对生殖器发育的理解总体上仍然非常有限。一个完整 了解控制生殖器发育和雄性化的遗传途径, 这些导致生殖器畸形的途径将有巨大的应用,以改善全球健康。在 在过去的几年里,我们对100名男性生殖器结节(GT)的发育进行了全面的遗传分析, 在小鼠体内建立了Wnt/β-catenin β Sp 8 → Fgf 8的保守遗传通路 附属物生长,包括四肢和外生殖器。Wnt和Shh之间的遗传相互作用 还描述了调节生殖器生长和雄性化的途径。在一起, 这些研究为理解胚胎后期发育以及 环境因素可影响生殖器发育,引起尿道下裂。根据这些发现, 这项建议将继续使用小鼠遗传学,包括一系列条件突变小鼠, 调节GT生长的新遗传途径。在目的I中,我们将表征几种敲除小鼠模型 来建立一个调节GT生长和模式的遗传途径。在Aim II中,我们将使用一种新颖且高度 创新的Split DamID技术用于识别雄激素受体和β-连环蛋白的体内下游靶点 在生殖器男性化过程中。这些研究加在一起,应该会大大提高我们对生殖器的理解 发育和尿道下裂形成。我们的长期目标是利用小鼠分子遗传学, 了解生殖器发育和男性化的过程以及生殖器畸形的病因, 例如尿道下裂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Liang Ma其他文献

Liang Ma的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Liang Ma', 18)}}的其他基金

Androgen and Wnt signaling in bladder cancer
膀胱癌中的雄激素和 Wnt 信号传导
  • 批准号:
    10727745
  • 财政年份:
    2023
  • 资助金额:
    $ 34.31万
  • 项目类别:
Retinoic acid signaling in decidualization
蜕膜化中的视黄酸信号传导
  • 批准号:
    10280145
  • 财政年份:
    2021
  • 资助金额:
    $ 34.31万
  • 项目类别:
Retinoic acid signaling in decidualization
蜕膜化中的视黄酸信号传导
  • 批准号:
    10619637
  • 财政年份:
    2021
  • 资助金额:
    $ 34.31万
  • 项目类别:
GENOME-WIDE IDENTIFICATION OF GENES REQUIRED FOR DECIDUALIZATION
蜕化所需基因的全基因组鉴定
  • 批准号:
    9258455
  • 财政年份:
    2016
  • 资助金额:
    $ 34.31万
  • 项目类别:
AN IN VITRO SCREENING TOOL FOR DECIDUALIZATION
一种用于分化的体外筛选工具
  • 批准号:
    8969886
  • 财政年份:
    2015
  • 资助金额:
    $ 34.31万
  • 项目类别:
GENERATION OF AN INDUCIBLE SYSTEM IN THE UTERINE STROMA FOR IMPLANTATION STUDIES
用于植入研究的子宫间质中诱导系统的生成
  • 批准号:
    8358586
  • 财政年份:
    2012
  • 资助金额:
    $ 34.31万
  • 项目类别:
GENERATION OF AN INDUCIBLE SYSTEM IN THE UTERINE STROMA FOR IMPLANTATION STUDIES
用于植入研究的子宫间质中诱导系统的生成
  • 批准号:
    8522211
  • 财政年份:
    2012
  • 资助金额:
    $ 34.31万
  • 项目类别:
EXTERNAL GENITALIA DEVELOPMENT AND HYPOSPADIAS
外生殖器发育和尿道下裂
  • 批准号:
    7656161
  • 财政年份:
    2009
  • 资助金额:
    $ 34.31万
  • 项目类别:
EXTERNAL GENITALIA DEVELOPMENT AND HYPOSPADIAS
外生殖器发育和尿道下裂
  • 批准号:
    8265869
  • 财政年份:
    2009
  • 资助金额:
    $ 34.31万
  • 项目类别:
Novel effectors of ERK signaling and their potential roles in the treatment of en
ERK 信号传导的新型效应物及其在治疗 en 中的潜在作用
  • 批准号:
    7727351
  • 财政年份:
    2009
  • 资助金额:
    $ 34.31万
  • 项目类别:

相似海外基金

Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
  • 批准号:
    DP230103210
  • 财政年份:
    2023
  • 资助金额:
    $ 34.31万
  • 项目类别:
    Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
  • 批准号:
    10584689
  • 财政年份:
    2023
  • 资助金额:
    $ 34.31万
  • 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
  • 批准号:
    10650956
  • 财政年份:
    2023
  • 资助金额:
    $ 34.31万
  • 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
  • 批准号:
    10488954
  • 财政年份:
    2023
  • 资助金额:
    $ 34.31万
  • 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
  • 批准号:
    10651105
  • 财政年份:
    2023
  • 资助金额:
    $ 34.31万
  • 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
  • 批准号:
    10603636
  • 财政年份:
    2023
  • 资助金额:
    $ 34.31万
  • 项目类别:
Androgen receptor function in melanoma
雄激素受体在黑色素瘤中的功能
  • 批准号:
    10416658
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
  • 批准号:
    10544062
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
  • 批准号:
    10534943
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
  • 批准号:
    10677989
  • 财政年份:
    2022
  • 资助金额:
    $ 34.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了